Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation on Novel Route of Gut Microbiota Products for Bariatric Surgery to Improve Non-alcoholic Steatohepatitis and Development on Therapeutic Implications

NCT04501042 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT04501042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04501042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation on Novel Route of Gut Microbiota Products for Bariatric Surgery to Improve Non-alcoholic Steatohepatitis and Development on Therapeutic Implications
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Unknown status
Start date
May 16, 2019
Completion date
September 1, 2024
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bariatric surgery, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis